Sentences with phrase «progression phase of the disease»

Not exact matches

The biotech specialist said that its updated phase 2 data in a study of its poziotinib candidate treatment for non-small cell lung cancer resulted in a preliminary confirmed objective response rate and potential progression - free survival benefit in patients with the EGFR Exon 20 Mutant form of the disease.

For example, Eli Lilly & Co. (NYSE: LLY) has a phase 3 study of solanezumab under way in mild to moderate Alzheimer's disease patients that may slow disease progression by breaking up amyloid plaque buildups thought to be a major cause of the disease.

Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial reported today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

«Adding radiation to chemotherapy may dramatically improve survival for advanced NSCLC: Randomized phase II trial finds progression - free survival expectancy nearly tripled with addition of consolidative stereotactic radiation therapy for limited metastatic disease.»

A drug used to treat men with late - stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University (OHSU).

A new combination of cancer drugs delayed disease progression for patients with hormone - receptor - positive metastatic breast cancer, according to a multi-center phase II trial.

CML patients treated with nilotinib had fewer treatment - emergent BCR - ABL mutations than those treated with imatinib, and among patients who did have a mutation, those treated with nilotinib had reduced rates of progression to accelerated phase and blast phase of the disease.

A phase III trial published last year showed that dabrafenib combined with trametinib in patients with metastatic disease was superior to dabrafenib alone, in terms of progression - free survival (22 % vs 12 % at 3 years; hazard ratio [HR], 0.71) and overall survival (44 % vs 32 % at 3 years; HR, 0.75).

Fluid therapy in the veterinary hospital or clinic has 3 primary phases, which can overlap and alternate, depending on how a patient presents and the progression of its disease process.

Oral medications can be initiated in the preclinical (asymptomatic) phase of dilated cardiomyopathy and in some cases, these medications can delay the progression of the disease to the development of congestive heart failure.